| Financial Year |
March 31 2023 |
| Monetary Funds |
625,660,620.62 |
| Held-for-trading Financial Assets |
1,274,280.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
917,576,588.55 |
| Advances to Suppliers |
82,766,393.24 |
| Other Receivables |
17,792,523.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,503,632,882.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,094,644.17 |
| Total Current Assets |
3,387,520,225.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
145,686,877.57 |
| Long-term Equity Investment |
58,529,346.99 |
| Investment Properties |
65,958,379.65 |
| Fixed Assetes |
3,814,117,310.61 |
| Under-construction Projects |
222,962,108.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
595,152,338.73 |
| R&D expenses |
152,026,646.54 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,857,513.44 |
| Deferred Income Tax Assets |
27,763,455.73 |
| Other Non-Current Assets |
44,599,755.21 |
| Sub-Total of Non-Current Assets |
5,161,424,933.28 |
| Total Assets |
8,548,945,159.23 |
| Short-Term Loans |
1,115,766,500.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
562,738,000.00 |
| Accounts Payable |
1,076,314,951.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,428,608.58 |
| Taxes Payable |
29,526,601.46 |
| Interest Payable |
-- |
| Dividend Payable |
1,680,905.49 |
| Other payables |
300,356,865.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
207,585,734.69 |
| Other Current Liabilities |
48,672,507.51 |
| Sub-Total of Current Liabilities |
3,526,689,113.33 |
| Long-term Loans |
1,236,885,323.06 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
123,857,705.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,453,075,095.20 |
| Total Liabilities |
4,979,764,208.53 |
| Paid-In Capital(Or Share Stock) |
888,873,468.00 |
| Capital Surplus |
1,642,160,896.43 |
| Surplus Reserve |
164,430,657.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
730,518,718.41 |
| Minority Stockholder's Interest |
152,038,506.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,417,142,444.68 |
| Owner's Equity（Stockholder's Equity） |
3,569,180,950.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,548,945,159.23 |
